Leadership is Made! Not Born!!- The Future Belongs to those who are Fast -

The future cannot help you unless you are willing to listen through the confusion. You cannot learn from the future if you are overwhelmed by the present or stuck in the past.The Republic of India faces a number of pressing challenges in health and health care. By 2020, if left unresolved, these challenges will not only lead to increased health insecurity but also to dramatic

PHARMACEUTICAL LEADERSHIP AWARDS 2011

Honouring Excellence in Healthcare & Pharmaceuticals

2011Gen-Next Indian Pharma Leaders

&

THE MAGAZINE FOR THE PHARMA LEADERS

- Re-Inventing Drivers for Growth -

Saturday,10th December,2011,

Hotel Lalit, Intercontinental, Mumbai, India

GROWTH : Bottomline in the healthcare economy

DISCIPLINE : Rationally Navigated

COLLAPSE : We were not Prepared

TRANSFORMATION : Foundation of Health Resiliency

1

Chairman's Message

GENERATION NEXT INDIA PHARMA LEADERS - Reinventing Driver's For Growth -

A

T

s we embark a full thoughtful analysis of Generation Next Pharma Leaders at Industry's most eagerly awaited thAnnual meet 4 Annual Pharmaceutical Leadership Summit & Awards 2011 to be staged by Pharmaleaders in

thassociation with Indo-American Chamber of Commerce ( IACC) on Saturday,10 December 2011 at Hotel Lalit

Intercontinental( Near Mumbai Airport), Mumbai , India, welcome to the brand new world of Generation Next Indian

Pharma Leaders who have risen under the shadow of their visionary fathers & has been instrumental in shaping up the

healthcare industry what it is today. A careful analysis of the present leadership transition & succession will reveal that

indeed, Indian pharmaceutical industry has been heading for a metamorphosis due to the induction of new way of thinking by

the Generation Next Pharmaceutical Pharma Leaders. The evolution of Indian pharmaceutical Sector since independence

has been the story of great show of resilience displayed by the patriarchs who dominated Indian pharma sector in reverese

engineering & operated under the domain of License Raj till the enunciation of economic liberalization in 1991 under the

visionary Finance Minister Manmohan Singh, currently PM. India was exposed to globalization & was thrown plethora of

challenges & opportunities.

he first three to four decade of the evolution of Indian Pharma sector saw the visionary legends who scripted the

growth story & brought milestone achievements against the powerful MNC's who continued their move to grab the

market share with their high Research-base product range. Late Dr Parvinder Singh of Ranbaxy, Dr Yusuf

Hameid of Cipla, I A Modi & Raman Bhai Patel of erstwhile Cadila group, Samprada Singh of Alkem, Suresh Kare of

Indoco, Habil Khorakiwala of Wockhardt are some of the notable names that fought against all odds & built-up rapidly

their respective empires. While many of the erstwhile regime has changed or diminished or renovated, the new emerging

power-equations have come in to fuel the growth engine. “I can say with all confidence & beyond any shadow of doubt that

these Pharma Leaders not only mapped the unorganized pharma market but got adapted to the emerging marketing

scenario as they changed their Type-Writer to modern day Laptop.While doing so, they went extra miles in Joint Ventures,

Acquisitions & Research outlook, leaving a rich legacy to their successors, only time can say that the rich leadership style

they practiced in bringing reforms to their own systems, how their sons, daughters & professional designated board will

be able to accelerate the pace”. Born with silver spoon in their mouth, these billionaire entrepreneurs featured in this story

also the others who due to lack of space or unavailability of authentic source of informations have taken the center stage of

their growth engine, so far, are struggling with ideas & remain deeply under the shadow & influence of their fathers, as the

change from past style to present regime where technological innovations have dominated the space with great speed.

Undoubtedly, the foremost fathers of these firms have grown tremendously although we are hearing of class of thoughts &

differences of opinions as the companies which was running with one leadership & command has seen the two power-centers

& the loyalty of interests has shifted two-fold as the employees try their best to please both father-son duo. While the old

school of thought led by the founder clearly have the edge in decision making process but their shadows clearly reflect in the

power struggle.

Glimpses of

2

Satya BrahmaChairman & Editor-In-ChiefIndian Affairs & Pharmaleaders Group

3

GENERATION NEXT INDIA PHARMA LEADERS

- Reinventing Driver's For Growth -

4

PROGRAMME

Opening Address – Mr. Satya Brahma, Editor-In-Chief, Pharma Leaders. Release of an exclusive white paper on Booming Pharma Industry – The Road Ahead 2015.

PROGRAM AGENDA : Saturday, 10th December, 2011

09:00 – 10:10 AM Registration & Refreshments

10:00-10:15 AM

Welcome Address : Dr Lalit S Kanodia,President Indo-American Chamber of Commerce (IACC), Western Region, & CMD, Datamatics Ltd.

10:15-10:30 AM

Inaugural Address : Shri Mahesh Zagade, IAS, commissioner of food and drug

administration (FDA) and food safety, Maharashtra.

10:30-11.00 AM

11.00-11.30 AM

Dr Shailesh Iyenger, MD, Aventis Pharma Ltd.

Keynote Address: Mr.Hasit Joshipura - MD, GSK India Ltd. Leadership Challenge for

the Gen-Next Indian Pharma Leaders. Lessons from the past, optimism for the future

1130-12.00PM

12.00-12.30 PM

12.30 -01.00 PM

12.00 -12.30 PM Keynote : The Gen-Next Indian Pharma Leaders : Leadership tips & Strategies.

Mr Ajit Singh, Chairman, ACG Worldwide.

12.30 -01.00 PM

01.00-02.00 PM Networking & Luncheon at Exhibition Hall

PROGRAMME

K e y n o t e A d d r e s s : R e b r a n d i n g P h a r m a L e a d e r s h i p : W h a t ' s t h e k e y t o s u c c e s s f o r the next generation of Pharma leaders? How Pharma can change its image from a leading rand expert. What does it take to shake off the negative connotations and be seen as a “star” industry again?. The key to success for the next generation of Pharma leaders will be to harness and focus institutional brilliance by becoming more disciplined, transparent and agile. Our experience with Pharmas is that they are loaded with forward thinking, technically brilliant, fast- and hard-working professionals. I've seen great strides in the development of organizational structures and processes designed to shift focus and resources from one priority to another. The challenge: That level of discipline currently resides at the top of most organizations. I believe there's a need for a much more systemic, top-to-bottom, bottom-to-top approach built around agile development principles. The current environment may well be the driver for that next level of alignment and focus.

Keynote Address : Dr. Rashmi Barbhaiya , CEO and Managing Director - Advinus Therapeutics Ltd. From Scientist To CEO. The

vision: Create a Pharmaceutical company focused on discovering and developing the next generation of high end commercialized

medicines. The best places to start? Recruiting next-generation leadership. In order to be successful, start-up biotechnology

andPharmaceutical companies need CEOs who are generalists, combining the necessary blend of business acumen, scientific

understanding, and communication skills.

Keynote: India : An Emerging Pharmaceutical Powerhouse : Dr Ajit V Dangi, Board Chairman, Fulford India Ltd. President &

CEO, Danseen Consulting .An Emerging Pharmaceutical Powerhouse. The presentation will cover Key strategic drivers for

profitable growth. Including enabling business environment, leveraging Intellectual property as a competitive strategy, building

international brands , inorganic growth thru` mergers , acquisitions and alliances, changing paradigm in Pharmaceutical R&D,

Biosimilar and OTC Opportunities , making India a Destination of Choice in CRAMS by moving from cost arbitrage to intellectual

a r b i t r a g e a n d c a p i t a l i z i n g o n h e a l t h c a r e r e f o r m s i n t h e d e v e l o p e d w o r l d .

Challenges & Oppourtunities of Nutraceutical Markets in India. Mr V.S.Reddy, CMD, British Biologicals Nutraceutical market is set to achieve a market size of Rs 90 billion in 2013 at a CAGR of 20.24%. Nutraceuticals are gaining acceptance globally for their ability to address several diseases. Vitamins, Minerals and Nutrients constitute about 85% of the global market whileantioxidants and anti-agents account for 10% other segments such as herbal extracts occupy 5% of the market. The US has been the major market for nutraceuticals with India and China becoming fastest growing markets.

02.00 - 02.30 PM Emergence of Biotech Entrepreneurs: Leadership role in 2010 : New Business Models for Breakthrough Growth : The Next-

Generation Pharmaceutical Value Chain. Dr Krishna Ella, CMD, Bharat Biotech International Ltd.

02:30-03:00 PM

03:00-03.30 PM

D r. C h a n d r a s h e k h a r P o t k a r, D i re c t o r, M e d i c a l a n d R e g u l a t o r y A f f a i r s , P f i z e r I n d i a L t d .It is becoming clear that targeting particular treatments to smaller patient populations is more effective than a “one-size-fits-all” approach. But is there an upside for drug manufacturers? Are there benefits which will outweigh the potential increase in marketing and R&D costs? This panel will look at new developments in personalised medicine and discuss whether it can be made to pay its way.

The case for personal ised medic ine – i s th is the fu ture and, i f so , how wil l we pay for i t?

D i f f e r e n t i a t e o r D i e - P h a r m a c e u t i c a l I n d u s t r y i n I n d i a .

The Pharma industry is awash with talk about the inevitable doom facing the medical rep. They speak of the medical rep as some

outdated, outmoded, non-thinking, inflexible, creature. A modern-day Dodo that cannot adjust to the changing environment around it.

The Pharma business environment, like any other business environment, has evolved over recent years. Most Pharma companies had

not fully anticipated the scale of this evolution and have found themselves reacting to change rather than leading it.Faced with reduced

access to their prescriber customers the Pharma industry's reaction was not to try and understand why access was falling and address the

root cause, but rather, to create additional trading faces to give them more opportunities for access. In the UK, the blame was laid at the

door of change in the political environment. GPs were now too busy with GP fundholding - their administrative load had increased - and

therefore they had less time to see reps. They were forced to have a minimum number of patients on their list so they had to amalgamate

into group practices - spec calls had declined and long-term appointment systems were making access more difficult. Mr.Deepak Naik,

M a n a g i n g D i r e c t o r H e a l t h ' N ' U T h e r a p e u t i c s P v t . L t d .

03.30-04.00 PM .Networking Refreshments Break at the Exhibition Hall

04.00-04.30 PM M r A n a n d D e s a i , N a t i o n a l P r e s i d e n t , I A C C & M a n a g i n g P a r t n e r , D S K L e g a l .

Do Pharmaceutical Companies Have Debt Crisis Strategy?. A Legal Perspective. The Obama Administration's proposed fiscal budget

for 2012 suggested that all bets are off for biopharmaceutical revenue safeguards, but it never had a chance with Congress, as evidenced

by a unanimous no-thank-you from the Senate in late May. But that was before debt ceiling talks and the alleged possibility of a default

emerged as the driver of the fiscal solvency debate.

04:30-05:00 PM Are FDI & Price Control Policy in Indian Pharma Sector deterrent for growth & Globalize Indian Healthcare

Industry.Dr.Kannan Vishwanath, Vice – Chairman & MD , Aanjaneya Lifecare Ltd

05:00-05:30 PM

05:30-06:00 PM

Mr Shailendra Singh, Joint Managing Director, Percept Limited The Art of Making a

Blockbuster Brand – Reviving DEAD to LIVE

.

Narayan Gad, CEO, Formulations, Panacea Biotech Ltd.

. Different stakeholders in the value chain, including healthcare providers, patient groups and

governments, will discuss the changing demands on the industry and how they can be reconciled with Pharma's commercial interests.

Issues for discussion will include: How can Pharma re-establish trust with patients, investors and diverse stakeholders? What do

different players in the healthcare system value, and how can the industry meet their needs? How can partnering enable the Pharma

industry to find new revenue streams? How does the Pharma business model need to change to capture value in new ways?

Moving beyond the healthcare debate : The Transformative Trends

That Will REALLY Define Our Future.

06.00 –06.30 PM

06:30-07:00 PM

Networking & Refreshments in Exhibition Hall

07.00 –07.30 PM PANELDISCUSSION: Generation Next Indian Pharma Leaders : Billioner Minds

Reinventing drivers for growth.

1.Satya Brahma, Editor-In-Chief, Pharmaleaders

2.Mr Daara Patel, Secretary General, IDMA

3.Mr Narayan Gad, CEO- Formulations, Panacea Biotech Ltd

4.Mr. Subodh Priolkar, President, IPA, President Colourcon Asia

5.Dr. Ajit. V. Dangi, President, Danseen Consulting

6.Mr Dinesh Mody, Director, JBCPL Ltd.

7.Dr.Kannan Vishwanath, Vice - Chairman 7 MD , Aanjaneya Lifecare Ltd.

Pharma's Value Proposition - How The Industry Must Change. Perspectives On Current Industry Challenges With Reference To Pfizer's Strategy”, Mr. Sunil Madhok, Director, Business Development, Pfizer India Ltd

Address by Chief Guest Shri Pranab Mukherjee, Finance Minister, Government of India. & 4th Annual

Pharmaceutical Leadership Awards 2011 presented by Finance Minister

08.00- 09.00 PM

Cocktail & Dinner with Entertainment Gala Celebration Night 090.00PM Onwards

- Reinventing Driver's For Growth -GENERATION NEXT INDIA PHARMA LEADERS

Summit Moderated By Mr S. Krishnakumar, Head, Future Steps

5

- Reinventing Driver's For Growth -

6

SPEAKERS

Mr. S. Krishnakumar : Head – Future Step

Mr. Satya Brahma, Editor-In-Chief, Pharma Leaders.

SPEAKERS

Krishnakumar is currently the Head of various initiatives to embrace & empower the diverse sectors with new age

talent management. Prior to this, he enjoyed memorable innings with reputed Companies such as FDC, Alkem, Warnbury etc & was

responsible for image building exercise & strategic acquisitions & leadership position in corporate decision making.

Future Step's

Satya Brahma is currently the Chairman of Network 7 Media group which has interest in media, publishing & events.

Over 12 years of Rich Experience in Journalism & Mass Communication out of which major parts of the career in

revising the framework of communications in India's Leading Corporate Houses & World's Largest NGO. Organized

& showcased some of India's biggest leadership events & his ability to stay unafraid is his biggest asset whilehe feels

that our life becomes meaningless the day when we lose hopes & ignore practical realities.

Dr. Lalit S. Kanodia, the founder and Chairman of Datamatics Group of Companies is one of the pioneers in the Indian

Software and Offshore Services Industry. He founded Datamatics in 1975, prior to which he was instrumental in setting up

of Tata Consultancy Services in 1967. Dr. Kanodia is an Executive Member of NASSCOM, the apex body of the IT-BPO

industry in India. He has also been designated as the Honorary Consul General of Chile in India by the Government of

Chile. In the past, he has held several eminent positions with various industry associations, which include- President of the

Management Consultant's Association of India and Chairman (Western Region) of the Electronics & Computer Software.

Dr. Kanodia has also been on the Board of Directors of several large conglomerates.

Dr. Lalit. S. Kanodia :

Zagade Is The Commissioner Of Food And Drug Administration (FDA) And Food Safety, Maharashtra. He serves as an Indian

Administrative Services ( IAS) & was in the past Head of various prestigious institutions of the Government.

Mr. Mahesh Zagade :

Dr. Shailesh Ayyangar is the Vice-President of OPPI & Managing Director, India & Vice President, South Asia, Aventis Pharma Ltd.,

(Group Sanofi Aventis). Dr. Ayyangar is a topper is the Post Graduate Programme in Business Management from the Indian Institute

of Management, Ahmedabad (IIMA). He started his career with Ranbaxy and then moved on to Eskayef Ltd. (SmithKline Beecham)

and later became the Vice President – Sales Operations for Pharmaceuticals for SmithKline Beecham. Later on, Dr. Ayyangar was

selected to direct the International Tropical Medicine Initiative of SmithKline Beecham in U.K. He returned to India in 2000 to

oversee the merger of SmithKline Beecham commercial operations with GlaxoWellcome and subsequent to the merger he took over

as Executive Vice President, Sales and Marketing in GlaxoSmithKline in India. In 2002, he left GSK to take over as Managing

Director of Sanofi-Synthelabo operations in India.

Dr. Shailesh Ayyangar :

Currently is CEO & MD of Advinus Therapeutics is an internationally reputed Pharma executive having extensive global experience

in handling diverse aspects of drug discovery and development. He has held several prestigious positions in leading pharmaceutical

companies and brings along an impeccable history in R&D operations and a successful background in business development and

deal making. Past offices held by Dr. Barbhaiya include President of Research and Development, Ranbaxy Research Laboratories,

New Delhi, India and Vice President in the Pharmaceutical Research Institute, Bristol-Meyers Squibb. In his 21 years with BMS and

about 2 years with Ranbaxy, Dr. Barbhaiya has been instrumental in discovery and development of numerous new drugs and drug

delivery products. Over his career, Dr. Barbhaiya has authored numerous publications (about 150) covering a broad range of

therapeutic areas. He obtained his PhD degree in Clinical Pharmacology from the St. Bartholomew's Hospital Medical College,

University of London and combined his education through post-doctoral training at the University of Florida and University of

Wisconsin.

Dr. Rashmi Barbhaiya :

Is President and CEO of Danssen Consulting , a consultancy firm specialising in Pharmaceuticals , Life Sciences and

Healthcare . He is also Chairman of the Board of Fulford India Ltd. a subsidiary of Merck & Co. Inc. , USA . Dr. Dangi

has served as Director General of Organisation of Pharmaceutical Producers of India ( OPPI ) , a premier Association of

Research based International Pharmaceutical Companies for over seven years, where he played a key role in bringing IPR

regime in India . He is former President & Executive Director of Johnson & Johnson Ltd., India where he served for 20

years in various capacities. Dr. Dangi also worked with Unilever Group Co. in U.K. for five years before returning to India.

Dr. Ajit Dangi

Chairman of Associated Capsules Group of Companies, Mumbai and Executive Committee Member of the Federation of

Indian Chambers of Commerce and Industry, is also the founder official of the South Asian Pharmaceutical Excepients

Council. A veteran entrepreneur, Singh is a well-known figure in the Indian pharmaceutical industry and is also actively

involved with various organizations, which work on issues affecting the pharmaceutical industry. He is a member of the

Scientific Committee of the Indian Herbal Pharmacoepia 2003 and also the Advisor to the US Pharmacoepia for India.

Mr. Ajit Singh,

Is the Founder Charman of British Biologicals.India's Forefront science based industry, the pharmaceutical industry, was

further catapulted with the founding of British Biologicals in 1988. The visionary genius Mr. V.S. Reddy, the founder, gave

a new thrust and direction in the field of Nutraceuticals and emerged, British Biologicals as an innovative and pioneering

Nutraceutical company.ban. Fondly called "the protein people", British Biologicals is in the forefront offering Nutritional

supplement in nutritionally beneficial and condition based specialties like General Nutrition, Diabetes, Pregnancy and

Lactation, Respiratory Disorders, Menopause and Hepatic dysfunctions. Perfection is a way of life at British Biologicals.

The organization has grown from a small beginning in 1988, to become a Nutraceutical company of international repute

for reliability.

Mr. V.S.Reddy

Ella is the CMD of Bharat Biotech International . Dr Ella pursued his early education in India and acquired his Postgraduate

Degree in Agricultural Sciences with Distinction and Gold Medals. After working with Sandoz (I) Ltd and Bayer, he

moved to the US for Higher Studies on a Rotary Foundation Scholarship. As a scientist par international standard, well

versed in the Plant/Human/Yeast systems, Dr. Ella has more than 30 scientific publications to his credit in peer reviewed

academic journals. His expertise in Gene Expression Systems has been well acclaimed and demonstrated, internationally.

He is a member of various high level Commissions.

Dr. Krishna Ella

Management and clinical research background with MD in Pharmacology from University of Mumbai, MBA from Deakin

University, Australia and thereafter his MS, Clinical Research Administration from the George Washington University,

USA. He is one of the founder governing council members and faculty at Academy for clinical Excellence, the training

center for clinical research at Mumbai in collaboration with Bombay College of Pharmacy and Suven. Dr. Potkar is also

the founder member of Indian Society for Clinical Research, the professional society for clinical research professionals in

India. He is a life member of Indian Psychiatry Society and Indian Pharmacology Society.

Dr. Chandrashekhar Potkar

Is the Managing Director of Health 'N' U Therapeutics Pvt. Ltd. Prior to setting up his own venture, Deepak held various

important positions in reputed companies such as Wockhardt, Ranbaxy etc. His last assignment was with Eisai

Pharmaceuticals India as Managing Director.

Mr. Deepak Naik

GENERATION NEXT INDIA PHARMA LEADERS

- Reinventing Driver's For Growth -

GENERATION NEXT INDIA PHARMA LEADERS - Reinventing Drivers For Growth -

7

GENERATION NEXT INDIA PHARMA LEADERS

8

SPEAKERS SPEAKERS

Generation Next Indian Pharma Leaders : Billionaire Minds, Reinventing

Drivers For Growth.

Mr. Satya Brahma, Editor-In-Chief, Pharmaleaders(Moderator)

Mr. Daara Patel, Secretary General, IDMA

Mr Narayan Gad, CEO- Formulations, Panacea Biotech Ltd

Mr. Subodh Priolkar, President, IPA, President Colourcon Asia

Dr. Ajit. V. Dangi, President, Danseen Consulting

Mr Dinesh Mody, Director, JBCPL Ltd.

Dr.Kannan Vishwanath, Vice - Chairman & MD, Aanjaneya Lifecare Ltd.

PANELDISCUSSION: 08.00 - 09.00 PM

Is the Managing Partner of reputed Legal firm DSK Legal. He also is the National President of Indo-American Chamber

of Commerce ( IACC). Anand has extensive specialist experience in the fields of banking laws, financial services,

M&A, intellectual property rights, media and entertainment, real estate, and outsourcing issues. Anand advises

various large corporates, funds and high networth individuals on diverse issues and has experience in advising the

s h i p p i n g a n d a v i a t i o n i n d u s t r y .

Mr. Anand Desai

Is the Joint Managing Director of Percept Limited, India's largest and only entertainment, media and communications conglomerate. An undying spirit, inexhaustible ideas, a fastidious attitude and a great eye for detail are what define the man, Shailendra Singh. His energy is rooted towards conceptualizing, planning and strategizing ways and means to creating innovative content that works. His expertise and contribution over the past two decades to the arena of Advertising, Sports, Talent, Movies and 360-degree communications are unparalleled, and truly make him the fastest innovator and creator in the entertainment, media and communications domain in India.

Mr. Shailendra Singh

is currently the CEO- Formulations of Indian Pharma Major Panacea Biotech Ltd. Prior to this assignment, Gad had a

successful tenure in reputed companies such as Dr reddy's Labs, Wockhard, Nicholas Piramal etc. Gad is a visiting

faculty to various Management Institutes & is a much sought after speaker on Management.

Mr.Narayan Gad

is currently the Director Business Devlopment with Pharma MNC Pfizer Ltd. Sunil has an illustrious career with a

successful track record.Sunil has been instrumental in success story of Pfizer India & is responsible for the business

devlopment in india.

Mr. Sunil Madhok

Is Promoter & Managing Director Aanjaneya Lifecare Limited . Innovative and results driven leader focused on achieving

exceptional results in highly competitive environments that demand continuous improvement. Experience in driving

product, process and customer service improvement while building partnerships with key business decision makers.

Consistently increased production, reduced operating costs and improved product quality by utilizing world class

manufacturing concepts ( lean manufacturing six sigma, theory of constraints etc ) to optimise & rationalize

manufacturing processes and supply chain networks Known for building and motivating cross functional teams that

exceed corporate expectations. Prior to this, Kannan was with BENZOCHEM LIFESCIENCES PVT LTD & was Was

responsible for a Team of 50 people with $ 10 million budget including supply chain functions two sites, distribution

network all inclusive from product conception, procurement, planning through quality and operations to customer

delivery

Dr.Kannan Vishwanath

GENERATION NEXT INDIA PHARMA LEADERS

- Reinventing Driver's For Growth - - ReInventing Drivers For Growth -

9 10

NOMINATIONS NOMINATIONS

Business Leader of the Year 2011

Business Woman of the Year 2011 ( Gen-Next Pharma Leader)

Dynamic Entreprenuer of the Year 2011

Pharma OTC Company of the Year 2011

India's Most Admired Nutrition & Neutraceuticals of the Year 2011

Company of the Year 2011

Pharma CSR Organization of the Year 2011

Pharma Professional Of the Year 2011 ( No Voting)

Lifetime Achievement Award of 2011 ( No Voting)

Brand of the Year 2011

Innovative R & D Company of the Year 2011

1. Dr Habil F Khorakiwala, Chairman, Wockhardt Ltd (Vote HFK to+ 91 9892108169)

2. Mr. Glenn Saldanha, Chairman & MD (Vote GS to+ 91 9892108169)

3. Kewal Handa, Managing Director, Pfizer & Merck Ltd. (Vote KH to+ 91 9892108169)

1. Mrs Vinita Gupta, Lupin LTD (Vote VG to+ 91 9892108169)

2. Mrs Aditi Kare Panandikar, Director, Indoco Remedies Ltd (Vote AK to+ 91 9892108169)

3. Ms. Nandini Piramal, Executive Director, Piramal Healthcare Limited, (Vote NP to+ 91 9892108169)

4. Dr Manu Chaudhary, JMD, Venus Remedies Ltd. (Vote MC to+ 91 9892108169)

1. Dr. GSK Velu, Founder, Trivitron Group of Companies (Vote GV to+ 91 9892108169)

2. Mr K Raghavendra Rao, Chairman & Managing Director,Orchid (Vote KR to+ 91 9892108169)

3. Dhirendra Kumar, Managing Director,Camson Biotechnologies Ltd,(Vote DK to+ 91 9892108169)

4. Dr Krishna Ella, CMD, Bharat Biotech International Ltd ( Vote KE to ++ 91 9892108169)

1. Alkem Health Foods (Vote AH to+ 91 9892108169)

2. Elder Pharmaceuticals Ltd (Vote EP to+ 91 9892108169)

3. Abbott Nutrition (Vote AN to+ 91 9892108169)

4. Ranbaxy Ltd ( Vote RAN to – 91 9892108169)

1. Apex Laboratories Ltd (Vote APEX to+ 91 9892108169)

2. Abbott Nutrition (Vote AB to+ 91 9892108169)

3. British Biological (Vote BB to+ 91 9892108169)

4. Novartis India Ltd. (Vote NI to+ 91 9892108169)

1. Twilight Litaka Pharma Ltd. (Vote TL to+ 91 9892108169)

2. Mankind Pharma Ltd (Vote MP to+ 91 9892108169)

3. Pfizer Ltd (Vote PL to+ 91 9892108169)

4. Abbott India Ltd (Vote LL to+ 91 9892108169)

1. Ranbaxy Ltd (Vote RL to+ 91 9892108169)

2. Wockhardt Foundation (Vote WF to+ 91 9892108169)

3. Zydus Cadila Ltd (Vote ZC to+ 91 9892108169)

4. Piramal Enterprises. (Vote PE to+ 91 9892108169)

1. Dr Kamal Sharma, MD, Lupin Ltd

2. Dr Ajit V Dangi, President & CEO, Danssen consulting

3. Mr Ranjit Shahani, Vice Chairman & MD, Novartis India Ltd.

1. J.B.Mody, Chairman J.B.Chemicals & Pharmaceuticals Ltd

2. Deepak Pahwa, Chairman, Pahwa Enterprises.

1. Revital (Vote RE to+ 91 9892108169)

2. B-COLEN (Vote BC+ 91 9892108169)

3. Becosule (Vote BE to+ 91 9892108169)

4. Violin (Vote VO to+ 91 9892108169)

5. Corex . ((Vote CO to+ 91 9892108169)

1. Bharat Biotech International Ltd. (Vote BBIL to+ 91 9892108169)

2. Glenmark Pharmaceuticals Ltd. (Vote GPL to+ 91 9892108169)

3. Zydus Cadila Ltd. (Vote ZC to+ 91 9892108169)

4. Cipla Ltd. (Vote CL to+ 91 9892108169)

India's Most Admire Surgeon Of the Year 2011 ( No Voting)

India's Fastest growing Pharmacy Retail chain 2011

Transformational Pharma Leader of the Year 2011 ( No Voting)

Excellence Innovators in Blood and Biological Products of the Year 2011

India's Most Admired Pharma Company 2011

India's Most Watched Company of the Year 2011

Emerging Company of the Year 2011

India's Most Admired Company in Bulk drugs 2011

India's Most Admired Company in Exports 2011

Research Scientist of the Year 2011

Multinational Company of The Year 2011

India's Most Admired Hospital Chain 2011.

Biotech Research Company of The Year 2011.

India's Most technically & scientifically advanced Pharmaceutical Manufacturing unit of the year 2011

1.Dr Devi Shetty, Chairman,Narayana Hrudayalaya.

1. Trust Chemist & Druggist Ltd. ((Vote TC to+ 91 9892108169)

2. Hetero Pharmacy Ltd. ((Vote HP to+ 91 9892108169)

3. Apollo Pharmacy. ((Vote AP to+ 91 9892108169)

4. Religare Pharmacy. ((Vote RP to+ 91 9892108169)

1. Dr Surinder Singh – Drug Controller General of India.

1. Synergy Dignostic Pvt Ltd. ((Vote SD to+ 91 9892108169)

2. El-Shaddai Biologicals Ltd. ((Vote EB to+ 91 9892108169)

3. VHB Lifesciences Ltd. ((Vote VL to+ 91 9892108169)

1. GSK Ltd ((Vote GSK to+ 91 9892108169)

2. Novartis India Ltd. (Vote NIL to+ 91 9892108169)

3. Abbott India Ltd. (Vote ALI to+ 91 9892108169)

4. Glenmark Ltd. (Vote GL to+ 91 9892108169)

5. Microlabs Ltd.(Vote ML to+ 91 9892108169)

1. Bliss GVS Pharma ((Vote BGV to+ 91 9892108169)

2. Novartis India Ltd. (Vote NL to+ 91 9892108169)

3. Abbott India Ltd. (Vote AI to+ 91 9892108169)

4. Glenmark Ltd. (Vote GL to+ 91 9892108169)

5. Galpha Labs Ltd. (Vote GAL to+ 91 9892108169)

1. Aanjaneya Lifecare Limited ((Vote ALL to+ 91 9892108169)

2. Bliss GVS Pharma . (Vote BGPL to+ 91 9892108169)

3. Lincoln Pharmaceuticals Ltd. (Vote LPL to+ 91 9892108169)

4. Venus Remedies Ltd. (Vote VRL to+ 91 9892108169)

5. Duraent Bilogicals ltd. (Vote DBL to+ 91 9892108169)

1. Hetero Drugs Ltd ((Vote HD to+ 91 9892108169)

2. Aarti Drugs Ltd . (Vote AD to+ 91 9892108169)

3. Parabolic Drugs Ltd. (Vote PDL to+ 91 9892108169)

4. Aurobindo Pharma Ltd . (Vote APL to+ 91 9892108169)

1. Ipca Labs Ltd. ((Vote IL to+ 91 9892108169)

2. Shreya Life-Sciences Ltd (Vote SLS to+ 91 9892108169)

3. Genom Biotech Ltd . (Vote GB to+ 91 9892108169)

4. Glenmark Ltd. (Vote GL to+ 91 9892108169)

5. Sun Pharmaceuticals Industries Ltd.(Vote SPIL to+ 91 9892108169)

1. Dr. Rashmi Barbhaiya, MD & CEO, Advinus Therapeutics Pvt Ltd,

1. Abbott India Ltd (Vote ABBT to+ 91 9892108169)

2. Pfizer India Ltd . (Vote PIL to+ 91 9892108169)

3. Gsk Ltd (Vote GSK to+ 91 9892108169)

4. Sanofi Aventis. (Vote SAL to+ 91 9892108169)

1. Fortis Healthcare Ltd. (Vote FH to+ 91 9892108169)

2. Appolo Healthcare Ltd . (Vote AHL to+ 91 9892108169)

3. Max Healthcare Ltd (Vote MAX to+ 91 9892108169)

4. Wockhardt Hospitals . (Vote WH to+ 91 9892108169)

1. Samarth Pharma Ltd. (Vote SPL to+ 91 9892108169)

2. Indegene Lifesystems Pvt. Ltd (Vote ILP to+ 91 9892108169)

3. Serum Institute of India (Vote SIP to+ 91 9892108169)

4. Avesthagen Limited (Vote AVS to+ 91 9892108169)

5. Adroit Biomed Limited ( Vote ADR to to+ 91 9892108169)

1. Aanjaneya Lifecare Ltd ( No Voting)

?

?

nominations@pharmasummit.in

11 12

Originally launched in 1999 as the Pharma Business & Technology Excellence Awards, these were first produced by the PHARMA BUSINESS & TECHNOLOGY MAGAZINE as a means of honoring innovation in pharmaceutical marketing, corporate governance and research and development & Lifetime Achievements category. Pharma Excellence Awards were produced by PBT Awards in India and expanded to recognize global corporate citizenship and individual achievements.As PBT Magazine wes discontinued, the task was taken up by the Management of Pharma Leaders Magazine. Over the Years, the awards was re-evaluated and recast to focus more on scientific accomplishments in industry and academic pharmaceutical research. The awards have been presented and at a sold-out gala award night. Since the institution of Leadership Awards, over 200 industry executives and leading academic scientists from around the world have been honoured. At a time when the pharma industry is facing some tough times—and the old way of doing things just won't work, Our Expert Judges roll out the selection methodology to felicitate the top honours. An independent panel of prominent society and industry leaders have been judging these awards. Winners have been selected via various processes & judging are based on information provided by the nominees. Finalists are notified in advance - in writing. The final winners are announced at the awards evening.

1. Business Leader of the Year 2011

2. Business Woman of the Year 2011 ( Gen-Next Pharma Leader)

3. Dynamic Entreprenuer of the Year 2011

4. Pharma OTC Company of the Year 2011

5. India's Most Admired Nutrition & Neutraceuticals of the Year 2011

6. Company of the Year 2011

7. Pharma CSR Organisation of the Year 2011

8. Pharma Professional Of the Year 2011 ( No Voting)

9. Lifetime Achievement Award of 2011 ( No Voting)

10. Brand of the Year 2011

11. Innovative R & D Company of the Year 2011

12. India's Most Admire Surgeon Of the Year 2011 ( No Voting)

13. India's Fastest growing Pharmacy Retail chain 2011

14. Transformational Pharma Leader of the Year 2011 ( No Voting)

15. Excellence Innovators in Blood and Biological Products of the Year 2011

16. India's Most Admired Pharma Company 2011

17. India's Most Watched Company of the Year 2011

18. Emerging Company of the Year 2011

19. India's Most Admired Company in Bulk drugs 2011

20. India's Most Admired Company in Exports 2011

21. Research Scientist of the Year 2011

22. Multinational Company of The Year 2011

23. India's Most Admired Hospital Chain 2011.

24. Biotech Research Company of The Year 2011.

25. India's Most Technically & Scientifically Advanced Pharmaceutical Manufacturing unit of the year 2011v

The Indian pharmaceutical industry in recent years has grown in stature from an industry that copies patent drugs and manufactures them cheaply. It's now counted among the industries that are fueling India's economic growth and holds vast potential. India-based pharmaceutical companies are also predicted to gain considerable market share in

the world by the end of this decade. The industry is estimated to have generated revenue worth US$13.1 billion in FY 2011. India-based companies fulfill around 70 percent of the country's demand for bulk drugs, drug intermediates, pharmaceutical formulations, chemicals, tablets, capsules, orals and injectibles. The Indian pharmaceutical industry is a “success story providing employment for millions and ensuring that essential drugs at affordable prices are available to the vast population of this sub-continent. Under these backdrops, Pharmaleaders will present the leading voices to debate at 4th Annual Pharmaceutical Leadership Summit 2011 which has never been debated in any platform.4Th Annual Pharmaceutical Leadership Summit & Awards 2011 is Asia's leading & prestigious Summit presented & organized by india's leading Pharma Bi-Monthly PHARMALEADERS in association with Indo-American Chamber of Commerce_IACC), delivering innovative, fully integrated and collaborative approaches to next generation Leadership Issues. 4Th Annual Pharmaceutical Leadership Summit 2011 is a CEO / Senior Management level, interactive Summit experience. The Summit speaker faculty are business and scientific pioneers from throughout Europe, US and Asia. Arguably, It is Asia's most prestigious interactive forum where ideas, intelligence and relationships really make a difference. The Summit attempts to tackles all the key strategic and collaborative issues facing the Pharmaceutical leadership transition and new blend of leadership, both today and in the future over a succinct 1-day programme. The 2011 Pharmaceutical Leadership Summit is where decision-makers from big pharma, early stage and mid stage vaccine biotechs, academia, government and regulatory bodies and key industry stakeholders meet to learn and innovate for the future. More than 250 who's & Who's of the Industry will attend this Summit.

AWARDS AWARDS

AN OVERVIEW

PHARMACEUTICAL

AWARDS CATEGORIES

LEADERSHIP 2011

13 14

PARTNERS PARTNERS

Pharma Leaders is a bi-monthly publication from Pharmaleaders Academy. It is the leading pharma title in

print and digital versions serving the information needs of key executives from the world's leading

pharmaceutical companies. Pharma Leaderscovers important issues and trends shaping the future of the

pharma industry across Asia and rest of the world. Pharma Leaders offers Dedicated, reliable and accurate

coverage of the industry's progress and Incisive analysis to help its readers make informed decisions to

stay ahead of the competition.The magazine provides cutting-edge and futuristic content on the pharma

Established in 1968, the Indo-American Chamber of Commerce (IACC) is a non-government, industry led and

industry-managed organization, playing a proactive role in Indias development process and serves as a much

needed link between the business communities of India and the United States of America. IACC is the only

bilateral Chamber of Commerce in India, which is committed to development of Indo-US business and trade

relations. The major objective of IACC is to promote Indo-American business, trade and economic relations.

IACC promotes bilateral trade, investment and technology transfer, facilitates business collaborations, joint

ventures, marketing tie-ups and strategic alliances through a set of proactive business-oriented initiatives.

Organisation of Pharmaceutical Producers of India (OPPI) established in 1965, is a premier association of

research based international and large pharmaceutical companies in India and is also a scientific and

professional body. It caters to the needs of Research based Pharmaceutical Industry thereby creating and

sustaining an environment conducive to innovation and growth, simultaneously, facilitating industry and

stakeholders partnership through various advisory and consultative processes to achieve the Healthcare

objectives of the Nation.

Indian Pharmaceutical Association (IPA) is the premier professional association of pharmacists in India, with a member base of over 10,000, spread across the length & breadth of the nation. IPA operates in India through 17 state branches & more than 33 local branches. The members represent various facets of pharmaceutical profession viz. Industry, regulatory, community pharmacy, hospital pharmacy & education. IPA is also actively associated in managing several academic programmes. As member of Drug Technical Advisory Board, India, IPA is actively involved in advising the government on matters of professional impotance. IPA is affiliated with international pharma associations like FIP, FAPA, CPA, AAPS, AAiPS, IPSF & WHO, for carrying out various collaborative professional activities which include organizing training programmes for professionals from industry, academics, regulatory & practice, making representations to the authorities on matters of professional interest & working towards constantly upgrading the standards of professional services offered by the pharmacists.

ndian Drug Manufacturers' Association (IDMA) was formed in 1961 to help Indian manufacturers and to protect the interest of the Indian consumer. Membership of over 800 wholly-Indian large, medium and small companies.Turnover of Indian pharma industry has grown exponentially from Rs.10 crore (about US 2million) in 1948 to about Rs. 1,00,000 crore (US $ 21 billion) today, a growth rate ofover15%.Members'Indian Market share – about 75% in formulations and about 85% in bulk drugs.Exports of about Rs. 50,000crore (over US $ 10 billion) last year growing at 22% average. Members' Export Record – about 65% of India's total drugs & pharma exports.More than 150 factories are approved by US FDA, UK-MCA, Australia and South Africa Authorities and many more are holding WHO-GMP certificates. India is ranked 3rd largest country in terms of production volume

All India Organisation of Chemists & Druggists - AIOCD has over about 5.5 Lac members from Retail Chemists

and Pharma Distributors/stockists. All these Members of AIOCD transact almost 95% of the overall pharma

business in India which is currently growing @12-to-13% on a year on year basis. AIOCD operates on PAN India

basis through all State and Union Territory level associations. AIOCD is the only true representative body of

pharma Trade in India. India being a vast country of diverse cultures, the problem of pharmaceuticals stockists and

retail chemists, also, varies from place to place. The tax structure being a state and federal subject, further

complicate the matter. The Pan India presence of AIOCD automatically evolves a role of a common link for them

between trade, pharma industry, government/regulators and community.

The dynamic growth of Indian Pharma Industry, a knowledge based industry, and the recommendations of four major

Pharma associations made the Ministry of Commerce & Industry to realize the need for separate export promotion

council. Accordingly, Pharmaceuticals Export Promotion Council (PHARMEXCIL) has been set up on 12.5.2004.

With its notification No.61 dt. 16.3.2005, Director General of Foreign Trade made Pharmexcil the sole agency to

issue RCMCs to all Pharma exporters. The activities of the Council are administered by Committee of Administration

consisting of representatives from major Pharma industries in India like J B Chemicals & Pharmaceuticals Limited,

Suven Life Sciences Limited, Dr. Reddy's Laboratories, Aurobindo Pharma, Luipin, Ranbaxy, Novarties, Avantis,

Ipca, Shasun, Sun Pharma, Zydus Cadila, Glowchem, Calyx etc., apart from Govt. officials from Central govt. and

Govt. of Andhra Pradesh. Administrative support to the Council is extended by very rich experienced personnel from

various fields like Govt. of India and Pharma industry.

The Bulk Drug Manufacturers Association (India) was formed in 1991 with Hyderabad as its Head Quarters. This is a n a l l I n d i a b o d y r e p r e s e n t i n g m o s t o f t h e B u l k D r u g M a n u f a c t u r e r s o f I n d i a . The Association works for the consolidation of gains of the industry and serves as a coordinator and catalyst between the government and the industry for the growth of the industry. Bulk Drug Industry is the backbone of the self-reliant Pharmaceutical industry in India, playing a significant role in improving the health standards of the people. Pharmaceutical manufacturers consisting of Formulations and Bulk Drugs and drug intermediates in large, medium and small scale sectors in the country employ man power of above 45 lakhs both directly and indirectly. The capital investment in the pharma industry is about Rs.35,000 crores. Today 90% of the domestic bulk drugs requirement is met by the Indian industry, itself. The Bulk Drug industry contributed about Rs. 48,000 Crores worth of exports, during the year 2010-2011 which is growing by over 15%-20% every year. Over 45% of the worlds bulk drug requirement is met by India.

The Pharmaceutical Wholesalers" Association (Bombay), is an independent body of Pharmaceuticals & Allied

Products Wholesalers of Mumbai. It provides safety, security and prosperity to its members. (The area under PWA

jurisdiction is Colaba to Dahisar in Western Track & upto Mulund in Central; in Harbour line the area is upto

Mankhurd). P.W.A plays the role of facilitator and meet the needs of our members, to know their aspirations and

respond creatively. To act as an interface between retail chemists and Industry. Our long-term success was; due to

transparency, commitment, working together effectively and willingness to be receptive to new ideas and learn

continuously. We shall formulate and amend our norms, which will ensure safety, security and prosperity of our

members. The inspirational spirit behind our work is our famous motto. “None of us is as strong as all of us”

Stage Craft India provide Audio-Video systems, stage hire and lighting for all types of events including –

Corporate events Theme parties Sports events Fashion shows Movie premiers Music launches Award nites

Brand launches Promotions Live concerts Televised shows We have over 20 years of experience in sound

reinforcement, sound systems, stage hire, lighting hire and design. We pride ourselves on our high levels of service,

experienced sound engineers and reliability.Our clients include event organizers, promoters, theatre companies,

companies, corporations, local authorities, festival organizers and artists. Stage Craft is dedicated to negotiating the

best possible terms for our clients. We can help you select the perfect mix of features and services within your

budgets

20 years ago Mr. Prashant & Mrs. Bijal Kalbag a husband & wife team launched Creative Awards & Rewards a company set up to provide 100% personalised solutions to meet the creative demands of its customers. With constant innovation a “Never Say No” attitude & by adding diverse materials into their existing range, the company has growth steadily into the established. The Company provides a bouquet of perfectly crafted products made of Metal, Steel, Crystal/Glass, Wood, Acrylic, Fiberglass, Soft PVC, Leather and Ceramic to suit every budget.Besides, Trophies, Presentation Plaques and Cups, Creative Awards also offers a range of Corporate and Promotional Gift items like Crystal Candle Holders/Paperweights/Min. Clocks/Ganeshas/Vases/ Glasses/ Bowls, Time Pieces – Wrist Watches/ Wall & Desktop Clocks, Stationery Items in Wood and Metal like Photo frames /Pens and Pen holders, Calendars, 1. Pen/Mobile & Visiting card holders, Miscellaneous Items like Coasters, Ceramic Mugs and Plates, Bar Sets…… and promotional and gift items made of Stainless Steel, Leather, Soft PVC, Lenticular Products as per y o u r d e s i g n a n d s p e c i f i c a t i o n s .The entire gamut of operations-right from computerized designing, crystal, metal casting, wooden, acrylic, painting and packaging department are all available under one roof to ensure quality and timely deliveries. So, to help you achieve the impact you seek, this mailer has been issued to especially inform you that we have come up with a new range of products in the above mentioned categories. Just give us a call & we will either send our Sales Representative across or will send to you a Video Mail of this new range. Alternatively, you could send us online

With a zest for continuous improvement, over the decades Print & Pack has provided the best printing applications and a wide range of services. with state–of-the–art technology and infrastructure. Print & Pack is hallmarked for being a one-stop solution for all printing needs for individuals, businesses and MNCs. We aim at optimizing brand representation of our clients with quality enhancement, time management and cost-effectiveness. As Print & Pack continuous to progress with technology, we still emphasize on old fashioned values like quality and loyalty. This has enabled us. to successfully convert the trust of every client into a lifetime relationship through unparalleled printing quality and services.

1615

Established in 1984, General Data Pvt Ltd provides customized solutions on demand. We provide services ranging from portals to full fledged corporate web solutions; from customized reporting tools to complete desktop and information sharing systems. Our unique process of problem analysis provides us a very effective efficient solution for maximum customer satisfaction. GDPL´s group Companies have agreement with various MNC´s and International Fortune 500 companies viz. Kodak Ltd. and Dupont which speaks about our integrity and quality consciousness. A new entity was founded in 1958 with the establishing of Gorakhram haribux - the first company to introduce car airconditioners in India. From then onwards, for over a span of 45 years, Our activities were growth-oriented. We diversified into Refrigeration system & Gases. Industrial Transformers, Conversion of jumbo Rolls of Photographic Color Paper and Graphic Art Film, Document Imaging, Sport & Leisure equipment and leasing of real Estate. Our group annual turnover is over Rs. 70 million with over 100 employees. Our Head Office is located at Nariman Point, Mumbai. Our Plants are located at Silvassa and Pune. We have Branches and Representatives in most major cities in India. The group has long-standing liaison and collaborations with foreign companies. International trade has made us quality conscious. While our cornerstone has always been co-operation, Mutual prosperity, solid

With a zest for continuous improvement, over the decades Adroit Digital Ideas has provided the best printing applications and a wide range of services. with state–of-the–art technology and infrastructure. Adroit is hallmarked for being a one-stop solution for all printing needs for individuals, businesses and MNCs. We aim at optimizing brand representation of our clients with quality enhancement, time management and cost-effectiveness. As Adroit continuous to progress with technology, we still emphasize on old fashioned values like quality and loyalty. This has enabled us. to successfully convert the trust of every client into a lifetime relationship through unparalleled printing quality and services.

Oxygen Infotainment is the one stop destination for the total infotainment solutions. As we believe "No matter how

creative and innovative your firm is the only software genuinely worth having is the customer relationship, based on

mutual advantage and trust. Individual, differentiable customer relationships will be the ultimate software of

businesses in the 1:1 future. All your products are ephemeral. Only your customers are real."

CARE WORLD TV, Asia's only Satellite healthcare TV Channel, emerged as the need of the hour by fulfilling a vacant niche, has successfully completed 2 years of disseminating health related information to the masses thus bridging the gap between the functionary and the beneficiary. Keeping in tune with the Boom in the healthcare Industry with constant changes, in trends , development , research , we have now re - launched 7 STAR CARE in a new Avatar as CARE WORLD a much improved version with an International & Contemporary feel with slick Presentation , state of the art Production values and exclusive Content. We offer various innovations in customized & interactive programming thus offering a range of formats for Health Industry to communicate their invaluable messages to a widespread and highly focused, and very responsive audience.CARE WORLD's prime focus and objective is to integrate health & fitness in its total sense encompassing Mind, Body, Beauty And Soul. With CARE WORLD we will continue our commitment & quest in serving the Masses and the Health industry and fulfill an ever expanding demand for health care information and services.

PR Newswire ( ) is the premier global provider of multimedia platforms that enable marketers,

corporate communicators, sustainability officers, public affairs and investor relations officers to leverage content to

engage with all their key audiences. Having pioneered the commercial news distribution industry 57 years ago, PR

Newswire today provides end-to-end solutions to produce, optimize and target content – from rich media to online

video to multimedia – and then distribute content and measure results across traditional, digital, mobile and social

channels. Combining the world's largest multi-channel, multi-cultural content distribution and optimization network

with comprehensive workflow tools and platforms, PR Newswire enables the world's enterprises to engage

opportunity everywhere it exists. PR Newswire serves tens of thousands of clients from offices in the Americas,

Europe, Middle East, Africa and the Asia-Pacific region, and is a UBM plc company.

www.prnewswire.com

Global Advertisers brings the talents of over 20 marketing professionals together to create the kind of strategic

thinking that sells. You can't move a product until you move a person and the advertising we generate has proven

extremely effective in doing just that. We create concept that stands out from the crowd, conveys a message that hits

home and sells your product or service. So contact us today and get the unstoppable services & unmatched packages.

Our talented creative people are all experts in their field and we always match the right skills to the right job.

PARTNERS

VENUE

GENERATION NEXT INDIA PHARMA LEADERS

- Reinventing Driver's For Growth -

AN ENDURING LANDMARK IN INDIA'S COMMERCIAL CAPITAL InterContinental The LaLiT Mumbai hotel represents understated luxury, a peaceful oasis from the frenetic city outside. Being at the nerve centre of the fastest developing business hub, Andheri, InterContinental The LaLiT Mumbai has easy access to other business districts of the financial capital of the country. InterContinental The LaLiT welcomes all its guests to the best airport hotel in the city, an ideal abode for the global traveler.InterContinental The LaLiT Mumbai projects a magnificent architectural façade with its 368 options of hotel accommodation Mumbai With Asia's largest Atrium Lobby, a lavish 7 story high feature welcoming the guests, this five star luxury hotels Mumbai is a marvelous combination of grandeur and sophistication.

Contact Details : Agatha Gomes,Sales Executive - Catering & Events InterContinental The LaLiT Mumbai Sahar Airport Road, Andheri East, Mumbai. Mobile : +91 9004653639Telephone Direct: +91-22- 30673375, Facsimile Direct: +91-22- 66998888, , agomes@thelalit.com www.thelalit.com

REGISTRATION

Gen-Next Indian Pharma Leaders

Billionaire Minds

-Re-Inventing Drivers for Growth-thSaturday,10 Dec,2011,Hotel Lalit Intercontinental, Airport Road,Mumbai,India

3RD ANNUAL PHARMACEUTICAL LEADERSHIP SUMMIT & AWARDS 2011

Registration Application

Registration Informations:

Per Delegate Fees: INR RS 10,000 + 10.30 SERVICE TAX

We are pleased to nominate the following participant(s) for the Summit:

Sr : Name : Designation:

Email id :

1.______________________________ _______________________ _______________

2.______________________________ _______________________ _______________

3.______________________________ _______________________ _______________

The DD / Cheque No. ________________ for Rs. ________________ towards the delegate fee drawn in

favour of “NOBLE SERVICES”, payable at Mumbai is enclosed.

Name:________________________________________________Designation :____________

Company:_____________________________________ IACC Membership No:

Address:_______________________________________________________________________________

Telephone:__________________________Fax:_________________________Mobile:_________________

Email:_________________________________________Website:_________________________________

Terms & Conditions

Summit Secretariat & Registration Desk.

The Delegate Fee is inclusive of the Service Tax and Education Cess @ 10.30%

ØA 10% discount for 3 or more delegates

ØDelegate fee non-refundable but change in nomination accepted

ØPayment can made via wire Transfer through Online Payments

Ø10% Discount to OPPI/IDMA/BDMA/IPA/PHARMEXCIL Members

Ø50% Discount to Indo-American Chamber of Commerce ( IACC) – Co-Organiser

4th Annual Pharmaceutical Leadership Summit 2011, Summit Secretariat. Noble Services, Accord Group of Companies,

Dimple Arcade, 3rd floor, 314, Asha Nagar, Landmark – Behind Sai Dham Mandir. Kandivali east, Mumbai – 400101. Mr.

Sohail Shaikh - 08888117599 , Mr. Mohsin Darvesh - 0810 8120 436 , Email :

ØPre-Registration and Pre-Payment is a must

pharmasummit2011@webnoble.co.in

1817 www.pharmasummit.in

19

THE GROUP

Network 7 Media Group Media Outfit is a result of emergence of an extreme thought process in the form

of some of the biggest & exclusive media properties that arose due to the frustration & disappointment of

the present status-quo of the society in existence in the form of a careless & extremely insensitive

administration of a large set-up. Network 7 Group has continuously strived to expose the misdeeds of

the corrupt administrative fabrics or poor legislation or failure of a large entity in corporate

governanance. Distinctively standing out of other media initiatives, Network 7 group has been in the

forefront of championing the cause of good governance & fair, unbiased & independent reporting in

national & international fields. Driven by the objective to address & deliberate some of the burning

issues, sometimes neglected causes, Network 7 Media Group Media Outfit is pioneering the concept of

introducing a fierce democratic process in the form a mass resistance in bringing into the forefront of

issues that matter most in the form of digital, printed, published, conclaves, summits & even in blogs &

letters shoot out to the authoritative. Headquartered in Mumbai, Network 7 Group Media Outfit is

backed & operated by some of the biggest think-tanks of the contemporary society whose ideas &

actions are reflected in the form of editorials & exclusive news findings. Network 7 Group Media is

present in the form of digital media production, publications, high-profile international events &

healthcare communications. Some of the flagship products of the Group are as follows .

INDIAN AFFAIRS: ( Business Magazine quarterly)

The timing of launching Indian Affairs Magazine ( www.indianaffairs.in ), "India's first ever Pink

Magazine on political, business, socio-economic & current affairs from Indian Affairs Pvt Ltd, a

flagship Company of Network 7 Group is driven by an objective to bring out ground-breaking true

stories to the Indian masses without any interference from lobbyists & corporate houses. The Pink

Magazine is present in the form of a digital & print editions. The editorial board of Indian Affairs is

composed of journalists in different sections of the society with wide-ranging areas of expertise in

business, political, investigative, international & cultural journalism. Their primary responsibility is

to write Indian Affairs's editorials, which represent the voice of the board, its editor and the publisher.

www.indianaffairs.in

PHARMA LEADERS : ( India's Most Analytical Bi-Monthly

Magazine on Healthcare)

Pharmaleaders,the flagship media outfit of Network 7 Group which also publishes India's leading

current affairs pink Magazine "INDIAN AFFAIRS" ( www.indianaffairs.in ) India's leading &

arguably one of the best news Magazine in Asia & has over the last one year emerged out as one of the

most credible voice with Independent & unbiased reporting in the healthcare industry. Known for its

accurate reporting &

direct uncomfortable questions to the leading voices of the Healthcare Industry, the objective of the

Magazine is to present facts & bring to the limelight the real face of the organization's interface to its

internal & external stakeholders. In line with, Corporate ethics & fair governance. Present in the form

of Digital & Printed publications, Pharmaleaders is the voice of the healthcare Industry in India. Today

Pharmaleaders is a leading title in Healthcare Media both in the form of Digital & Printed Publications.

www.pharmaleaders.co.in

Pharmanewsprwire : is India's Only Pharma Press Distribution Newswire Agency that address the

needs of disseminating informations to the targeted audiences. Pharmanewsprwire is a vibrant platform

of knowledge sharing & dissemination of informations on the latest trends, news & analysis of the

entire gamut of the healthcare industry.Behind the infrastructure of pharmaprnewswire.comand its

powerful database of thousands of Pharmanewsprwire is a dedicated team of experts in all aspects of

media communications.Our people are highly experienced journalists, editors and publishers, with

high-profile media careers on leading newspapers and magazines around the country.We keep our

finger on the pulse, keeping up to date with movements across the industry so our database is as current

as possible.

THE GROUP

20

2011: A Springboard Year

T

Biggest Challenges that we all are facing!

he Summit is your best opportunity to acquire knowledge of lessons learned, gain information regarding current practice,

promising opportunities, impending influences, and insights into developments that become expectations of our

organizations. For whatever time you may devote to participation with us, PHARMA LEADERS BOARD is determined to

provide a great conference at a time when it is greatly needed. Your Summit experience will be one of knowledge acquisition, staff

development, marketplace awareness and exposure to those trends and issues most relevant to educational technologies and services.

The core of what we are about is support of the institutions we represent, in particular Healthcare. Your Board and I look forward to

effectively serving you, helping you to address and resolve barriers encountered in achieving excellence in addressing some of the

It is always easier to do ten-year forecasting than one-year forecasting, but it is especially true now. Stuck in 2011, it seems impossibly difficult to forecast the future because the present is so messy. Now however—in the midst of the mess—is exactly the time when ten-year forecasting can be most valuable. 2011 is authentically frightening, but it also has great potential to be a springboard year. Volatility, uncertainty, complexity, and ambiguity are likely to get worse in 2011. Many people are already choking on uncertainty most of the time—especially people on the down side of the rich/poor gap. Some leaders are still expecting a return to predictability. As someone who has been doing ten-year forecasting for more than thirty-five years, let me be very clear about my view: if you are not confused by 2011 and the future we are facing, you are not paying attention. The future cannot help you unless you are willing to listen through the confusion. You cannot learn from the future if you are overwhelmed by the present or stuck in the past. I believe that the next decade, beginning in 2011, will be characterized by both danger and opportunity. Leaders will be buffeted, but they need not allow themselves to be depressed or immobilized. Leaders must do more than just respond to crises, though respond they must. Some of today's leaders have already turned nasty out of frustration, with considerable cause. Still, leaders can be positive change agents in the midst of chaos. Some things can get better, even as other things get worse. Organizations need a readiness discipline that assumes uncertainty, but achieves success nonetheless. Ten-year forecasters can help leaders gain perspective by looking long. One of the reasons for the current economic crisis is that short-term betting dominated long-term thought in many marketplaces. Foresight can provoke insight, even if you don't agree with the forecast. A discipline of thinking from foresight to insight to action leads—almost always—to better decisions in the present. Problem-solvers beware: even though solvable problems will still abound in the next decade, top leaders will deal mostly with dilemmas where there is no solution—but where you have to make decisions anyway. The best leaders will thrive in the space between judgment too soon (the classic mistake of the problem solver) and deciding too late (the classic mistake of the academic). Leaders will not be able to control or problem solve through volatility, uncertainty, complexity, and ambiguity. Leaders must learn how to see through the mess with a global futures perspective, to sense patterns of change. That is what ten-year forecasting is all about. 2019 is much more clear than 2011, if only leaders take the time to look long. We know, for example, that 2019 will be a world with sensors and wireless everywhere—even in the developing world. We know that Facebook generation will be in leadership positions by 2019, though their ways of leading are only just becoming apparent. My assessment is that 2011 is the beginning of a threshold decade: our natural systems will reach tipping points of extreme challenge and some of those systems may break. Our business, organizational, and social systems will be stretched too, some of them to the breaking point. We also know that we will be even more connected in 2019 than we are today. I believe that the more connected we are, the safer we are, the more free we are, and the more powerful we are—if we realize the benefits of connectivity. We are more connected than ever before and we are—almost everyone is—globally connected. But there are downsides: the more connected we are, the more dangerous it can be, as our current economic crisis is revealing. Leaders must make the links, draw the connections, organize people for action—but protect against the dangers inherent in super-connectivity. Leaders must engage with chaotic global future forces and figure out how to make a better future. Certainly, the focus for many people in 2011 must be on holding the fort and surviving. But in every organization, there should be at least a small band of leaders with license to think about and plan for the future. 2011 is threatening, but it is also an ideal time to be looking ahead—beyond the current crises. If we stew ourselves in 2011, we'll never get to 2019. Those organizations that do nothing but hunker down in this crisis will be way behind when things start getting better. Leaders can make the future, but they won't make it all at once and they can't make it alone. 2011 can be a springboard year, if leaders use foresight to spark their own insight and inform their own action.

21

GENERATION NEXT INDIA PHARMA LEADERS - Reinventing Driver's For Growth -

WHERE ARE WE? WHERE ARE WE?

2222

NOTES

Your Take Away From the Summit

2223

NOTES

Your Take Away From the Summit

2224

NOTES

Your Take Away From the Summit